Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?
De Marco
S
S
Fabi
A
A
Ceribelli
A
A
Carlini
P
P
Pollera
C F
CF
Cognetti
F
F
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010146:Pain / Q000209:etiology*; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine